| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 02/07/2008 | US20080032288 Labeling Reagents, Methods for the Synthesis of Such Reagents and Methods for the Detection of Biological Molecules |
| 02/07/2008 | DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria |
| 02/07/2008 | CA2659703A1 Method for introducing a nucleic-acid-protecting group |
| 02/06/2008 | EP1883646A1 A1 adenosine receptor agonists |
| 02/06/2008 | CN101117346A Process for the preparation of 2'-halo-beta-l-arabinofuranosyl nucleosides |
| 02/05/2008 | US7326780 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA |
| 01/31/2008 | WO2008014252A2 Iap inhibitors |
| 01/31/2008 | WO2008013322A1 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors. |
| 01/31/2008 | WO2008013321A1 Novel sglt inhibitors |
| 01/31/2008 | WO2008013280A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008013277A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
| 01/31/2008 | WO2008012949A1 Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
| 01/31/2008 | WO2008012945A1 3'-ethynylcytidine derivative |
| 01/31/2008 | US20080028480 Markers for Salinity Tolerance in Wheat Plants and the Use Thereof in Breeding Programs |
| 01/31/2008 | US20080027014 Novel SGLT inhibitors |
| 01/31/2008 | US20080026466 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life |
| 01/31/2008 | US20080026381 Sequencing nucleic acid molecules; promote accurate base-over-base incorporation in sequencing-by-synthesis reactions, resulting in greater read lengths |
| 01/31/2008 | US20080026380 Nucleotide analogs |
| 01/31/2008 | CA2659595A1 Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
| 01/31/2008 | CA2658923A1 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes |
| 01/31/2008 | CA2658921A1 Fused ring spiroketal derivative and use thereof as anti-diabetic drug |
| 01/31/2008 | CA2658917A1 3'-ethynylcytidine derivative |
| 01/30/2008 | EP1882748A2 A population of nucleic acids including a subpopulation of LNA oligomers |
| 01/30/2008 | EP1881991A1 A1 adenosine receptor agonists |
| 01/30/2008 | CN101115765A Modified 5'-phosphonates of azt potential antiviral drugs |
| 01/30/2008 | CN100364534C Use of n-substituted-1,5-di deoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 01/29/2008 | US7323555 Nucleotide derivative and DNA microarray |
| 01/29/2008 | US7323453 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 01/29/2008 | US7323451 Crystalline and amorphous forms of beta-L-2′-deoxythymidine |
| 01/29/2008 | US7323449 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 01/24/2008 | WO2008011406A2 Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| 01/24/2008 | WO2008011335A2 Metal binding compounds, metal binding compositions, and their uses |
| 01/24/2008 | WO2008010571A1 2'-cyanopyrimidine nucleoside compound |
| 01/24/2008 | WO2007128086A3 Novel viral replication inhibitor |
| 01/24/2008 | WO2007090071A3 6-modified bicyclic nucleic acid analogs |
| 01/24/2008 | WO2007053702A3 Synthesis of four color 3'-o-allyl modified photocleavable fluorescent nucleotides and related methods |
| 01/24/2008 | US20080021208 Gemcitabine Prodrugs, Pharmaceutical Compositions and Uses Thereof |
| 01/24/2008 | US20080021206 2'-O-cyanoethyluridine; 2'-O-cyanoethylcytidine; 2'-O-cyanoethyladenosine; 2'-O-cyanoethylguanosine; economically obtained with the use of acrylonitrile as its introducing agent; used as a chemical agent for the synthesis of a nucleic acid or as modified RNA |
| 01/24/2008 | US20080021205 Methods and Compositions for Use in Preparing Hairpin Rnas |
| 01/24/2008 | US20080020997 Glucosamine and Glucosamine/Anti-Inflammatory Mutual Prodrugs, Compositions, and Methods |
| 01/24/2008 | US20080020989 Cancer, hepatitis C virus infection, mmunomodulators; Acetic acid 2-acetoxymethyl-5-(5-formylamino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-isopropoxycarbonyloxy-tetrahydro-furan-3-yl ester |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1879906A2 Reversible nucleotide terminators and uses thereof |
| 01/23/2008 | EP1711825A4 Conjugated small molecules |
| 01/23/2008 | EP1570090A4 A biological sample storage device and method for biological sample contamination testing |
| 01/23/2008 | EP1570043A4 Device and method for in-line blood testing using biochips |
| 01/23/2008 | EP1509622A4 Fluorescence polarization detection of nucleic acids |
| 01/23/2008 | EP1307469B1 Nucleic acid binding compounds containing pyrazolo¬3,4-d pyrimidine analogues of purin-2,6-diamine and their uses |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | CN101111509A Novel pyrimidine nucleoside compound or its salt |
| 01/23/2008 | CN101111508A Spiroketal derivative and use thereof as diabetic medicine |
| 01/23/2008 | CN101111462A Process for production of fluoro derivative |
| 01/23/2008 | CN101108871A Technique for extracting cycli phosphate adenosine from chinese date |
| 01/23/2008 | CN101108870A Process for preparation of nucleoside phosphoric acid ester compound and application thereof |
| 01/23/2008 | CN100363377C N heterocyclic substituted adenosine derivatives |
| 01/23/2008 | CN100363376C Crystallization process of 5'-nucleoside sodium triphosphate |
| 01/22/2008 | US7321033 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus |
| 01/22/2008 | US7321029 High RNA binding affinity to complementary nucleic acids and are base and acid stable; treatment of cancer, viral infections |
| 01/17/2008 | WO2008007728A1 Oral preparation in the form enclosed in lipid membrane structure, and fatigue-ameliorating agent comprising coenzyme a as active ingredient |
| 01/17/2008 | WO2008006563A1 Purine derivatives as a2a agonists |
| 01/17/2008 | WO2008006369A1 Adenosine receptor antagonists |
| 01/17/2008 | WO2007136817A3 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 01/17/2008 | WO2007092936A3 Method to treat gastric lesions |
| 01/17/2008 | US20080015350 Used in the manufacture of other forms of beta-L-2'-deoxythymidine (telbivudine); increased solubility, improved bioavailability, ease of chemical processing and/or ease of pharmaceutical formulation; hepatitis B |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015138 Metal binding compounds, metal binding compositions, and their uses |
| 01/17/2008 | US20080014582 Methods and compositions for detecting fungi and mycotoxins |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | CA2656012A1 Purine derivatives as a2a agonists |
| 01/16/2008 | EP1877415A2 New labelling strategies for the sensitive detection of analytes |
| 01/16/2008 | EP1876894A1 Nucleoside compounds and methods of use thereof |
| 01/16/2008 | CN101107261A Imidazopyridine derivative |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319101 catechol-O-methyltransferase (COMT) inhibitors such as N-{3-[5-(6-Amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-allyl}-2,3-dihydroxy-benzamide used for the treatment of schizophrenia, Parkinson's disease and as antidepressants or cognition activators |
| 01/15/2008 | US7319093 Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives |
| 01/15/2008 | US7319021 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell |
| 01/15/2008 | CA2493724C Process for the preparation of 9-beta-anomeric nucleoside analogs |
| 01/15/2008 | CA2215176C C-nucleoside derivatives and their use in the detection of nucleic acids |
| 01/10/2008 | WO2008005542A2 Antiviral phosphinate compounds |
| 01/10/2008 | WO2007134181A3 5'-modified bicyclic nucleic acid analogs |
| 01/10/2008 | WO2007121920A3 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/10/2008 | US20080009612 Novel Polynucleotide Synthesis Labeling Chemistry |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009462 Metabolically Stable Alkoxyalkyl Esters of Antiviral or Antiproliferative Phosphonates, Nucleoside Phosphonates and Nucleoside Phosphates |
| 01/10/2008 | US20080009461 Therapeutic compounds |
| 01/10/2008 | CA2656525A1 Reversible terminator nucleotides and methods of use |
| 01/09/2008 | EP1874790A2 New s-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases |
| 01/09/2008 | EP1874789A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use |
| 01/09/2008 | CN101100478A Method for synthesizing d4T-5'-hydroisopropyl phosphite |
| 01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/09/2008 | CN100360528C Preparation of 4-amino-1-(2-methylol-1,3-oxapentane-5-group)-2(1H)-pyrimidone |
| 01/08/2008 | CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/08/2008 | CA2319777C Dideoxy dye terminators |
| 01/03/2008 | WO2008001718A1 Dehydroxylated fluorinating agent |
| 01/03/2008 | WO2008001495A1 Agent against psychosocial stresses |
| 01/03/2008 | WO2008000745A2 Adenosine derivatives for the treatment of pain |
| 01/03/2008 | WO2008000743A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 01/03/2008 | WO2007130951A3 Methods and apparatus for sequential amplification reactions |
| 01/03/2008 | WO2007122333A3 Process for preparing disulphides and thiosulphinates and compounds prepared |
| 01/03/2008 | US20080005808 transgenic plants transformed with nucleotide sequence coding for vesicle transport stress-related polypeptides or resulting in gene expression of increased growth and/or increased drought resistance |